Article Details

Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety

Retrieved on: 2024-07-29 14:16:42

Tags for this article:

Click the tags to see associated articles and topics

Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety. View article details on hiswai:

Excerpt

The European Medicines Agency has rejected a marketing ... Personalised advertising and content, advertising and content measurement, audience research ...

Article found on: www.bmj.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up